1 Study Coverage
1.1 Marek's Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Marek's Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bivalent Vaccine
1.2.3 Monovalent Vaccine
1.3 Market by Application
1.3.1 Global Marek's Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Marek's Disease Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Marek's Disease Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Marek's Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Marek's Disease Vaccine Sales by Region
2.4.1 Global Marek's Disease Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Marek's Disease Vaccine by Region (2023-2028)
2.5 Global Marek's Disease Vaccine Revenue by Region
2.5.1 Global Marek's Disease Vaccine Revenue by Region (2017-2022)
2.5.2 Global Marek's Disease Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Marek's Disease Vaccine Sales by Manufacturers
3.1.1 Global Top Marek's Disease Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Marek's Disease Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Marek's Disease Vaccine in 2021
3.2 Global Marek's Disease Vaccine Revenue by Manufacturers
3.2.1 Global Marek's Disease Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Marek's Disease Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Marek's Disease Vaccine Revenue in 2021
3.3 Global Marek's Disease Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Marek's Disease Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Marek's Disease Vaccine Sales by Type
4.1.1 Global Marek's Disease Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Marek's Disease Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Marek's Disease Vaccine Revenue by Type
4.2.1 Global Marek's Disease Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Marek's Disease Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Marek's Disease Vaccine Price by Type
4.3.1 Global Marek's Disease Vaccine Price by Type (2017-2022)
4.3.2 Global Marek's Disease Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Marek's Disease Vaccine Sales by Application
5.1.1 Global Marek's Disease Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Marek's Disease Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Marek's Disease Vaccine Revenue by Application
5.2.1 Global Marek's Disease Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Marek's Disease Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Marek's Disease Vaccine Price by Application
5.3.1 Global Marek's Disease Vaccine Price by Application (2017-2022)
5.3.2 Global Marek's Disease Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Marek's Disease Vaccine Market Size by Type
6.1.1 North America Marek's Disease Vaccine Sales by Type (2017-2028)
6.1.2 North America Marek's Disease Vaccine Revenue by Type (2017-2028)
6.2 North America Marek's Disease Vaccine Market Size by Application
6.2.1 North America Marek's Disease Vaccine Sales by Application (2017-2028)
6.2.2 North America Marek's Disease Vaccine Revenue by Application (2017-2028)
6.3 North America Marek's Disease Vaccine Market Size by Country
6.3.1 North America Marek's Disease Vaccine Sales by Country (2017-2028)
6.3.2 North America Marek's Disease Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Marek's Disease Vaccine Market Size by Type
7.1.1 Europe Marek's Disease Vaccine Sales by Type (2017-2028)
7.1.2 Europe Marek's Disease Vaccine Revenue by Type (2017-2028)
7.2 Europe Marek's Disease Vaccine Market Size by Application
7.2.1 Europe Marek's Disease Vaccine Sales by Application (2017-2028)
7.2.2 Europe Marek's Disease Vaccine Revenue by Application (2017-2028)
7.3 Europe Marek's Disease Vaccine Market Size by Country
7.3.1 Europe Marek's Disease Vaccine Sales by Country (2017-2028)
7.3.2 Europe Marek's Disease Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Marek's Disease Vaccine Market Size by Type
8.1.1 Asia Pacific Marek's Disease Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Marek's Disease Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Marek's Disease Vaccine Market Size by Application
8.2.1 Asia Pacific Marek's Disease Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Marek's Disease Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Marek's Disease Vaccine Market Size by Region
8.3.1 Asia Pacific Marek's Disease Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Marek's Disease Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Marek's Disease Vaccine Market Size by Type
9.1.1 Latin America Marek's Disease Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Marek's Disease Vaccine Revenue by Type (2017-2028)
9.2 Latin America Marek's Disease Vaccine Market Size by Application
9.2.1 Latin America Marek's Disease Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Marek's Disease Vaccine Revenue by Application (2017-2028)
9.3 Latin America Marek's Disease Vaccine Market Size by Country
9.3.1 Latin America Marek's Disease Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Marek's Disease Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Marek's Disease Vaccine Market Size by Type
10.1.1 Middle East and Africa Marek's Disease Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Marek's Disease Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Marek's Disease Vaccine Market Size by Application
10.2.1 Middle East and Africa Marek's Disease Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Marek's Disease Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Marek's Disease Vaccine Market Size by Country
10.3.1 Middle East and Africa Marek's Disease Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Marek's Disease Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Ceva
11.2.1 Ceva Corporation Information
11.2.2 Ceva Overview
11.2.3 Ceva Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ceva Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ceva Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd.
11.5.1 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Corporation Information
11.5.2 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Overview
11.5.3 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
11.6 Merial
11.6.1 Merial Corporation Information
11.6.2 Merial Overview
11.6.3 Merial Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merial Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merial Recent Developments
11.7 Ruipu Biopharmaceutical Co., Ltd.
11.7.1 Ruipu Biopharmaceutical Co., Ltd. Corporation Information
11.7.2 Ruipu Biopharmaceutical Co., Ltd. Overview
11.7.3 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments
11.8 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
11.8.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
11.8.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Overview
11.8.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
11.9 Beijing Huadu Shihua Biological Products Co., Ltd.
11.9.1 Beijing Huadu Shihua Biological Products Co., Ltd. Corporation Information
11.9.2 Beijing Huadu Shihua Biological Products Co., Ltd. Overview
11.9.3 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
11.10 Guangxi Lichengdong Biological Co., Ltd.
11.10.1 Guangxi Lichengdong Biological Co., Ltd. Corporation Information
11.10.2 Guangxi Lichengdong Biological Co., Ltd. Overview
11.10.3 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Guangxi Lichengdong Biological Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Marek's Disease Vaccine Industry Chain Analysis
12.2 Marek's Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Marek's Disease Vaccine Production Mode & Process
12.4 Marek's Disease Vaccine Sales and Marketing
12.4.1 Marek's Disease Vaccine Sales Channels
12.4.2 Marek's Disease Vaccine Distributors
12.5 Marek's Disease Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Marek's Disease Vaccine Industry Trends
13.2 Marek's Disease Vaccine Market Drivers
13.3 Marek's Disease Vaccine Market Challenges
13.4 Marek's Disease Vaccine Market Restraints
14 Key Findings in The Global Marek's Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Marek's Disease Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Bivalent Vaccine
Table 3. Major Manufacturers of Monovalent Vaccine
Table 4. Global Marek's Disease Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Marek's Disease Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Marek's Disease Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Marek's Disease Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Marek's Disease Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Marek's Disease Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Marek's Disease Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Marek's Disease Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Marek's Disease Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Marek's Disease Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Marek's Disease Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Marek's Disease Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Marek's Disease Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Marek's Disease Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Marek's Disease Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Marek's Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Marek's Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marek's Disease Vaccine as of 2021)
Table 21. Marek's Disease Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Marek's Disease Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Marek's Disease Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Marek's Disease Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Marek's Disease Vaccine Sales Share by Type (2017-2022)
Table 28. Global Marek's Disease Vaccine Sales Share by Type (2023-2028)
Table 29. Global Marek's Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Marek's Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Marek's Disease Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Marek's Disease Vaccine Revenue Share by Type (2023-2028)
Table 33. Marek's Disease Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Marek's Disease Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Marek's Disease Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Marek's Disease Vaccine Sales Share by Application (2017-2022)
Table 38. Global Marek's Disease Vaccine Sales Share by Application (2023-2028)
Table 39. Global Marek's Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Marek's Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Marek's Disease Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Marek's Disease Vaccine Revenue Share by Application (2023-2028)
Table 43. Marek's Disease Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Marek's Disease Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Marek's Disease Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Marek's Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Marek's Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Marek's Disease Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Marek's Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Marek's Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Marek's Disease Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Marek's Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Marek's Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Marek's Disease Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Marek's Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Marek's Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Marek's Disease Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Marek's Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Marek's Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Marek's Disease Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Marek's Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Marek's Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Marek's Disease Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Marek's Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Marek's Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Marek's Disease Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Marek's Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Marek's Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Marek's Disease Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Marek's Disease Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Marek's Disease Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Marek's Disease Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Marek's Disease Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Marek's Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Marek's Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Marek's Disease Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Marek's Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Marek's Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Marek's Disease Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Marek's Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Marek's Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Marek's Disease Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Marek's Disease Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Marek's Disease Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Marek's Disease Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Marek's Disease Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Marek's Disease Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Marek's Disease Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Marek's Disease Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Marek's Disease Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Marek's Disease Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Marek's Disease Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Marek's Disease Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Merck Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Recent Developments
Table 110. Ceva Corporation Information
Table 111. Ceva Description and Major Businesses
Table 112. Ceva Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Ceva Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Ceva Recent Developments
Table 115. Zoetis Corporation Information
Table 116. Zoetis Description and Major Businesses
Table 117. Zoetis Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Zoetis Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Zoetis Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Boehringer Ingelheim Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Corporation Information
Table 126. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Description and Major Businesses
Table 127. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Guangdong Wen's Dahuanong Biotechnology Co., Ltd. Recent Developments
Table 130. Merial Corporation Information
Table 131. Merial Description and Major Businesses
Table 132. Merial Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Merial Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Merial Recent Developments
Table 135. Ruipu Biopharmaceutical Co., Ltd. Corporation Information
Table 136. Ruipu Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 137. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Ruipu Biopharmaceutical Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Ruipu Biopharmaceutical Co., Ltd. Recent Developments
Table 140. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
Table 141. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Major Businesses
Table 142. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments
Table 145. Beijing Huadu Shihua Biological Products Co., Ltd. Corporation Information
Table 146. Beijing Huadu Shihua Biological Products Co., Ltd. Description and Major Businesses
Table 147. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Beijing Huadu Shihua Biological Products Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Beijing Huadu Shihua Biological Products Co., Ltd. Recent Developments
Table 150. Guangxi Lichengdong Biological Co., Ltd. Corporation Information
Table 151. Guangxi Lichengdong Biological Co., Ltd. Description and Major Businesses
Table 152. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Guangxi Lichengdong Biological Co., Ltd. Marek's Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Guangxi Lichengdong Biological Co., Ltd. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Marek's Disease Vaccine Distributors List
Table 158. Marek's Disease Vaccine Customers List
Table 159. Marek's Disease Vaccine Market Trends
Table 160. Marek's Disease Vaccine Market Drivers
Table 161. Marek's Disease Vaccine Market Challenges
Table 162. Marek's Disease Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Marek's Disease Vaccine Product Picture
Figure 3. Global Marek's Disease Vaccine Market Share by Type in 2021 & 2028
Figure 3. Bivalent Vaccine Product Picture
Figure 4. Monovalent Vaccine Product Picture
Figure 5. Global Marek's Disease Vaccine Market Share by Application in 2021 & 2028
Figure 6. Veterinary Pharmacy
Figure 7. Online Sale
Figure 8. Others
Figure 9. Marek's Disease Vaccine Report Years Considered
Figure 10. Global Marek's Disease Vaccine Sales 2017-2028 (K Units)
Figure 11. Global Marek's Disease Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Marek's Disease Vaccine Revenue 2017-2028 (US$ Million)
Figure 13. Global Marek's Disease Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Marek's Disease Vaccine Sales Market Share by Region (2017-2022)
Figure 15. Global Marek's Disease Vaccine Sales Market Share by Region (2023-2028)
Figure 16. North America Marek's Disease Vaccine Sales YoY (2017-2028) & (K Units)
Figure 17. North America Marek's Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Marek's Disease Vaccine Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Marek's Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Marek's Disease Vaccine Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Marek's Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Marek's Disease Vaccine Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Marek's Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Marek's Disease Vaccine Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Marek's Disease Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Marek's Disease Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Marek's Disease Vaccine in the World: Market Share by Marek's Disease Vaccine Revenue in 2021
Figure 28. Global Marek's Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 32. Global Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 33. North America Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 34. North America Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. North America Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 36. North America Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America Marek's Disease Vaccine Sales Share by Country (2017-2028)
Figure 38. North America Marek's Disease Vaccine Revenue Share by Country (2017-2028)
Figure 39. U.S. Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 42. Europe Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Marek's Disease Vaccine Sales Share by Country (2017-2028)
Figure 46. Europe Marek's Disease Vaccine Revenue Share by Country (2017-2028)
Figure 47. Germany Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. France Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Marek's Disease Vaccine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Marek's Disease Vaccine Revenue Share by Region (2017-2028)
Figure 58. China Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. India Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Marek's Disease Vaccine Sales Share by Country (2017-2028)
Figure 73. Latin America Marek's Disease Vaccine Revenue Share by Country (2017-2028)
Figure 74. Mexico Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Marek's Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Marek's Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Marek's Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Marek's Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Marek's Disease Vaccine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Marek's Disease Vaccine Revenue Share by Country (2017-2028)
Figure 83. Turkey Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Marek's Disease Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. Marek's Disease Vaccine Value Chain
Figure 87. Marek's Disease Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
